• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过无创电导率测量法测定重组白细胞介素-2引起的毛细血管渗漏。

Determination of capillary leakage due to recombinant interleukin-2 by means of noninvasive conductivity measurements.

作者信息

Olthof C G, Baars J W, Wagstaff J, Donker A J, Schneider H, de Vries P M

机构信息

Department of Anaesthesiology, Free University Hospital, Amsterdam, The Netherlands.

出版信息

Eur J Appl Physiol Occup Physiol. 1993;67(2):168-73. doi: 10.1007/BF00376662.

DOI:10.1007/BF00376662
PMID:8223524
Abstract

One of the most common side effects of treatment with recombinant interleukin-2 (IL-2) is capillary leakage. Its genesis is not completely understood. The aim of the study was to determine whether capillary leakage can be monitored by means of a noninvasive conductivity technique and to study its starting point. Eight patients with advanced renal cell cancer were studied in a medium care section of the Department of Medical Oncology, University Hospital over 4 days during treatment sessions of continuous, intravenously administered IL-2 (mean dose of 15.6 x 10(6) IU.m-2.day-1). The fluid shift from the intravascular to the extra- and intracellular compartments was monitored by means of noninvasive conductivity measurements. Changes in blood volume were calculated from serial erythrocyte counts. The clinical parameters of capillary leakage (oliguria, positive fluid balance, and gain in mass) were recorded. The mean gain in mass was 9% after 4 days of IL-2 treatment. The extracellular fluid volume increased significantly [46 (SD 23.2)%; P < 0.01], whereas the intracellular fluid volume did not change. The increase in blood volume (BV) amounted to 7% (P < 0.05). The decline in albumin concentration was significantly more than the increase in BV [38 (SD 4.3)%; P < 0.01], indicating capillary albumin leakage. The main changes were observed after the 2nd day of treatment. From this study, it is suggested that conductivity measurements are a suitable method to monitor capillary leakage induced by IL-2, and could be used to detect the exact onset and severity of this leakage.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

重组白细胞介素 -2(IL -2)治疗最常见的副作用之一是毛细血管渗漏。其发病机制尚未完全明确。本研究旨在确定是否可以通过无创电导率技术监测毛细血管渗漏,并研究其起始点。在大学医院医学肿瘤学系的中级护理病房,对8例晚期肾细胞癌患者进行了为期4天的研究,期间持续静脉注射IL -2(平均剂量为15.6×10⁶IU·m⁻²·天⁻¹)。通过无创电导率测量监测液体从血管内转移到血管外和细胞内间隙的情况。根据连续红细胞计数计算血容量变化。记录毛细血管渗漏的临床参数(少尿、正液体平衡和体重增加)。IL -2治疗4天后平均体重增加9%。细胞外液体积显著增加[46(标准差23.2)%;P < 0.01],而细胞内液体积未改变。血容量(BV)增加了7%(P < 0.05)。白蛋白浓度的下降明显超过BV的增加[38(标准差4.3)%;P < 0.01],表明存在毛细血管白蛋白渗漏。主要变化在治疗第2天后观察到。从本研究可知,电导率测量是监测IL -2诱导的毛细血管渗漏的合适方法,可用于检测这种渗漏的确切起始时间和严重程度。(摘要截断于250字)

相似文献

1
Determination of capillary leakage due to recombinant interleukin-2 by means of noninvasive conductivity measurements.通过无创电导率测量法测定重组白细胞介素-2引起的毛细血管渗漏。
Eur J Appl Physiol Occup Physiol. 1993;67(2):168-73. doi: 10.1007/BF00376662.
2
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
J Exp Ther Oncol. 1996 May;1(3):155-61.
3
Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.重组白细胞介素-2全身给药介导的血管内液体外渗
J Immunol. 1986 Sep 1;137(5):1735-42.
4
The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.重组白细胞介素-2免疫治疗期间多形核中性粒细胞和补体系统的激活
Br J Cancer. 1992 Jan;65(1):96-101. doi: 10.1038/bjc.1992.18.
5
Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.重组白细胞介素-2持续静脉输注治疗转移性肾细胞癌:一项单中心II期研究。
J Clin Oncol. 1992 May;10(5):753-9. doi: 10.1200/JCO.1992.10.5.753.
6
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2.持续静脉输注白细胞介素-2期间血浆硝酸盐加亚硝酸盐的变化。
Br J Cancer. 1996 Oct;74(8):1297-301. doi: 10.1038/bjc.1996.533.
7
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.低剂量重组白细胞介素-2持续长时间输注治疗黑色素瘤和肾细胞癌的I期研究。第一部分:临床情况。
Br J Cancer. 1992 May;65(5):744-50. doi: 10.1038/bjc.1992.157.
8
Increase of rat pulmonary microvascular permeability to albumin by recombinant interleukin-2.重组白细胞介素-2增加大鼠肺微血管对白蛋白的通透性。
Cancer Res. 1987 Jul 1;47(13):3528-32.
9
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.NG-硝基-L-精氨酸甲酯,一种一氧化氮合成抑制剂,可改善白细胞介素2诱导的毛细血管渗漏,并减少荷腺癌小鼠的肿瘤生长。
Br J Cancer. 1996 Jan;73(2):189-96. doi: 10.1038/bjc.1996.34.
10
Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer.重组白细胞介素2治疗晚期癌症所致左心室充盈率受损。
Br Heart J. 1994 Feb;71(2):166-9. doi: 10.1136/hrt.71.2.166.

引用本文的文献

1
Mechanism of cytokine modulation of epithelial tight junction barrier.细胞因子调节上皮紧密连接屏障的机制。
Front Biosci (Landmark Ed). 2009 Jan 1;14(7):2765-78. doi: 10.2741/3413.

本文引用的文献

1
The use of antipyrine in the measurement of total body water in man.安替比林在人体全身水含量测量中的应用。
J Biol Chem. 1949 May;179(1):31-42.
2
SIMULTANEOUS DETERMINATION OF EXTRACELLULAR VOLUME AND BLOOD VOLUME WITH THE VOLEMETRON.使用容量计同时测定细胞外液量和血容量。
Clin Chim Acta. 1965 Mar;11:270-7. doi: 10.1016/0009-8981(65)90074-4.
3
Non-invasive conductivity method for detection of dynamic body fluid changes: in vitro and in vivo validation.
Nephrol Dial Transplant. 1993;8(1):41-6. doi: 10.1093/oxfordjournals.ndt.a092270.
4
Interstitial fluid volume: local regulatory mechanisms.组织液容量:局部调节机制。
Physiol Rev. 1981 Jul;61(3):556-643. doi: 10.1152/physrev.1981.61.3.556.
5
Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.采用LAK细胞和重组白细胞介素-2对已形成的肺转移瘤进行过继性免疫治疗。
Science. 1984 Sep 28;225(4669):1487-9. doi: 10.1126/science.6332379.
6
Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.通过全身给予高剂量重组白细胞介素2介导已建立的肺转移瘤和皮下肿瘤的消退。
J Exp Med. 1985 May 1;161(5):1169-88. doi: 10.1084/jem.161.5.1169.
7
Conductivity measurements for analysis of transcellular fluid shifts during hemodialysis.
ASAIO Trans. 1987 Jul-Sep;33(3):554-6.
8
Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.重组白细胞介素-2全身给药介导的血管内液体外渗
J Immunol. 1986 Sep 1;137(5):1735-42.
9
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.关于使用淋巴因子激活的杀伤细胞和白细胞介素-2或单独使用高剂量白细胞介素-2治疗157例晚期癌症患者的进展报告。
N Engl J Med. 1987 Apr 9;316(15):889-97. doi: 10.1056/NEJM198704093161501.
10
Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice.小鼠体内通过全身注射淋巴因子激活的杀伤细胞和重组白细胞介素-2介导的器官血管通透性增加。
J Natl Cancer Inst. 1988 Apr 6;80(3):177-88. doi: 10.1093/jnci/80.3.177.